Glaxosmithkline Llc Pac (Gsk Pac) APR MONTHLY Filings
| Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
|---|---|---|---|---|---|---|
| 2024 | April 19 | March 31 | $22,874.30 | $78,096.26 | $14,220.44 | |
| 2024 | April 14, 2023 | March 31, 2023 | $22,211.91 | $96,780.87 | $7,971.55 | |
| 2022 | April 12, 2022 | March 31, 2022 | $23,214.82 | $108,083.35 | $81,233.94 | |
| 2020 | April 3, 2020 | March 31, 2020 | $24,673.85 | $56,579.94 | $175,047.83 | |
| 2020 | April 19, 2019 | March 31, 2019 | $26,478.13 | $29,903.32 | $165,828.98 | |
| 2018 | April 19, 2018 | March 31, 2018 | $32,084.60 | $43,553.21 | $138,808.15 | |
| 2018 | April 20, 2017 | March 31, 2017 | $32,203.57 | $123,064.08 | $55,725.58 | |
| 2016 | April 20, 2016 | March 31, 2016 | $29,576.32 | $78,572.08 | $149,928.26 | |
| 2016 | April 20, 2015 | March 31, 2015 | $38,083.65 | $120,674.44 | $152,930.87 | |
| 2014 | April 18, 2014 | March 31, 2014 | $42,267.36 | $62,043.89 | $139,489.72 | |
| 2014 | April 17, 2013 | March 31, 2013 | $62,521.26 | $80,078.52 | $137,409.99 | |
| 2012 | April 20, 2012 | March 31, 2012 | $63,477.68 | $89,967.61 | $133,885.92 | |
| 2012 | April 15, 2011 | March 31, 2011 | $44,906.69 | $143,136.90 | $55,198.86 | |
| 2010 | April 16, 2010 | March 31, 2010 | $62,839.31 | $85,452.94 | $174,335.73 | |
| 2010 | Sept. 18, 2009 | March 31, 2009 | Compare to original | $66,886.15 | $137,474.00 | $149,272.52 |
| 2008 | Sept. 18, 2009 | March 31, 2008 | Compare to original | $72,909.80 | $61,500.00 | $173,684.00 |
| 2008 | April 13, 2007 | March 31, 2007 | $79,473.82 | $104,652.82 | $244,896.06 | |
| 2006 | April 19, 2006 | March 31, 2006 | $81,103.76 | $126,550.00 | $570,141.35 | |
| 2006 | April 15, 2005 | March 31, 2005 | $86,867.30 | $56,000.00 | $355,304.00 | |
| 2004 | April 12, 2004 | March 31, 2004 | View | View | ||
| 2004 | April 16, 2003 | March 31, 2003 | View | View | ||
| 2002 | Oct. 29, 2002 | March 31, 2002 | View | View | ||
| 2002 | April 16, 2001 | March 31, 2001 | View | View |